New drug duo tested in fight against tough head & neck cancers
Disease control
Ongoing
This study is testing if combining two existing cancer drugs, docetaxel and pembrolizumab, is a safe and effective treatment for people with advanced head and neck cancer that has come back or spread. It aims to see if this combination can help shrink tumors and help patients liv…
Phase: PHASE2 • Sponsor: Hokkaido University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC